25 XP   0   0   10

Lexicon Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Lexicon Pharmaceuticals Inc together

PenkeI guess you are interested in Lexicon Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lexicon Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lexicon Pharmaceuticals Inc

I send you an email if I find something interesting about Lexicon Pharmaceuticals Inc.

Quick analysis of Lexicon Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Lexicon Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$0.38
Expected worth in 1 year
$0.28
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.10
Return On Investment
-6.2%

For what price can you sell your share?

Current Price per Share
$1.58
Expected price per share
$0.9596 - $3.73
How sure are you?
50%

1. Valuation of Lexicon Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$1.58

Intrinsic Value Per Share

$-6.55 - $-4.66

Total Value Per Share

$-6.17 - $-4.28

2. Growth of Lexicon Pharmaceuticals Inc (5 min.)




Is Lexicon Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$93.1m$106.1m$20.5m16.2%

How much money is Lexicon Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$43.6m-$25.7m-$17.8m-40.9%
Net Profit Margin-45,249.2%-76,501.9%--

How much money comes from the company's main activities?

3. Financial Health of Lexicon Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#379 / 1010

Most Revenue
#575 / 1010

Most Profit
#869 / 1010

Most Efficient
#984 / 1010

What can you expect buying and holding a share of Lexicon Pharmaceuticals Inc? (5 min.)

Welcome investor! Lexicon Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Lexicon Pharmaceuticals Inc.

What can you expect buying and holding a share of Lexicon Pharmaceuticals Inc?

First you should know what it really means to hold a share of Lexicon Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Lexicon Pharmaceuticals Inc is $1.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lexicon Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lexicon Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.38. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lexicon Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-12.4%-0.18-11.3%-0.10-6.6%-0.06-3.8%-0.08-5.1%
Usd Book Value Change Per Share-0.19-11.9%-0.02-1.5%0.000.2%0.021.5%-0.01-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.19-11.9%-0.02-1.5%0.000.2%0.021.5%-0.01-0.5%
Usd Price Per Share1.53-1.84-2.07-3.13-6.26-
Price to Earnings Ratio-1.95--2.78--5.08--8.20--12.65-
Price-to-Total Gains Ratio-8.12--7.17--13.76--131.35--87.15-
Price to Book Ratio4.05-3.95-5.03-0.12--9.54-
Price-to-Total Gains Ratio-8.12--7.17--13.76--131.35--87.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.58
Number of shares632
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.02
Usd Total Gains Per Share-0.020.02
Gains per Quarter (632 shares)-15.4115.35
Gains per Year (632 shares)-61.6461.38
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-62-7206151
20-123-1340123112
30-185-1960184173
40-247-2580245234
50-308-3200307295
60-370-3820368356
70-431-4440429417
80-493-5060491478
90-555-5680552539
100-616-6300614600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%3.037.00.07.5%4.092.00.04.2%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%8.032.00.020.0%22.074.00.022.9%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%5.00.035.012.5%8.00.088.08.3%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%8.032.00.020.0%22.074.00.022.9%

Fundamentals of Lexicon Pharmaceuticals Inc

About Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Fundamental data was last updated by Penke on 2024-04-11 13:55:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lexicon Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lexicon Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -6,872.4% means that $-68.72 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -6,872.4%. The company is making a huge loss. -2
  • The TTM is -45,249.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-6,872.4%TTM-45,249.2%+38,376.8%
TTM-45,249.2%YOY-76,501.9%+31,252.8%
TTM-45,249.2%5Y-42,995.0%-2,254.2%
5Y-42,995.0%10Y-22,552.5%-20,442.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6,872.4%-207.2%-6,665.2%
TTM-45,249.2%-216.8%-45,032.4%
YOY-76,501.9%-282.3%-76,219.6%
5Y-42,995.0%-436.8%-42,558.2%
10Y-22,552.5%-597.3%-21,955.2%
1.1.2. Return on Assets

Shows how efficient Lexicon Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • -21.0% Return on Assets means that Lexicon Pharmaceuticals Inc generated $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -21.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.0%TTM-18.1%-2.9%
TTM-18.1%YOY-17.0%-1.1%
TTM-18.1%5Y-8.5%-9.6%
5Y-8.5%10Y-8.0%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.0%-13.3%-7.7%
TTM-18.1%-12.8%-5.3%
YOY-17.0%-11.6%-5.4%
5Y-8.5%-13.8%+5.3%
10Y-8.0%-15.6%+7.6%
1.1.3. Return on Equity

Shows how efficient Lexicon Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • -51.8% Return on Equity means Lexicon Pharmaceuticals Inc generated $-0.52 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -51.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.8%TTM-13.0%-38.9%
TTM-13.0%YOY-10.5%-2.5%
TTM-13.0%5Y-3.7%-9.2%
5Y-3.7%10Y-14.2%+10.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.8%-16.9%-34.9%
TTM-13.0%-16.1%+3.1%
YOY-10.5%-14.9%+4.4%
5Y-3.7%-19.3%+15.6%
10Y-14.2%-20.1%+5.9%

1.2. Operating Efficiency of Lexicon Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lexicon Pharmaceuticals Inc is operating .

  • Measures how much profit Lexicon Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of -6,657.7% means the company generated $-66.58  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is -6,657.7%. The company is operating very inefficient. -2
  • The TTM is -44,720.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-6,657.7%TTM-44,720.8%+38,063.1%
TTM-44,720.8%YOY-74,783.6%+30,062.8%
TTM-44,720.8%5Y-42,543.6%-2,177.2%
5Y-42,543.6%10Y-22,187.4%-20,356.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6,657.7%-298.0%-6,359.7%
TTM-44,720.8%-238.5%-44,482.3%
YOY-74,783.6%-288.4%-74,495.2%
5Y-42,543.6%-486.2%-42,057.4%
10Y-22,187.4%-628.4%-21,559.0%
1.2.2. Operating Ratio

Measures how efficient Lexicon Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 67.58 means that the operating costs are $67.58 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 67.577. The company is inefficient in keeping operating costs low. -1
  • The TTM is 454.687. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ67.577TTM454.687-387.110
TTM454.687YOY751.212-296.525
TTM454.6875Y427.905+26.783
5Y427.90510Y232.169+195.736
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ67.5773.235+64.342
TTM454.6873.310+451.377
YOY751.2123.838+747.374
5Y427.9055.679+422.226
10Y232.1697.823+224.346

1.3. Liquidity of Lexicon Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lexicon Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.60 means the company has $5.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 5.596. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.000. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.596TTM7.000-1.403
TTM7.000YOY5.536+1.463
TTM7.0005Y5.014+1.986
5Y5.01410Y4.451+0.563
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5963.863+1.733
TTM7.0004.169+2.831
YOY5.5365.337+0.199
5Y5.0146.122-1.108
10Y4.4516.434-1.983
1.3.2. Quick Ratio

Measures if Lexicon Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 10.10 means the company can pay off $10.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 10.099. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.977. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.099TTM11.977-1.878
TTM11.977YOY8.944+3.033
TTM11.9775Y7.708+4.269
5Y7.70810Y7.047+0.662
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0993.504+6.595
TTM11.9773.991+7.986
YOY8.9445.371+3.573
5Y7.7086.088+1.620
10Y7.0476.395+0.652

1.4. Solvency of Lexicon Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lexicon Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lexicon Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.59 means that Lexicon Pharmaceuticals Inc assets are financed with 59.4% credit (debt) and the remaining percentage (100% - 59.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 0.594. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.490. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.594TTM0.490+0.104
TTM0.490YOY0.334+0.156
TTM0.4905Y0.526-0.036
5Y0.52610Y0.599-0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5940.339+0.255
TTM0.4900.337+0.153
YOY0.3340.271+0.063
5Y0.5260.368+0.158
10Y0.5990.388+0.211
1.4.2. Debt to Equity Ratio

Measures if Lexicon Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 146.4% means that company has $1.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lexicon Pharmaceuticals Inc:

  • The MRQ is 1.464. The company is able to pay all its debts with equity. +1
  • The TTM is 0.366. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.464TTM0.366+1.098
TTM0.366YOY0.200+0.166
TTM0.3665Y0.721-0.355
5Y0.72110Y1.436-0.715
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4640.392+1.072
TTM0.3660.403-0.037
YOY0.2000.335-0.135
5Y0.7210.427+0.294
10Y1.4360.461+0.975

2. Market Valuation of Lexicon Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lexicon Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Lexicon Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -1.95 means the investor is paying $-1.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lexicon Pharmaceuticals Inc:

  • The EOD is -2.016. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.952. Based on the earnings, the company is expensive. -2
  • The TTM is -2.776. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.016MRQ-1.952-0.064
MRQ-1.952TTM-2.776+0.824
TTM-2.776YOY-5.078+2.302
TTM-2.7765Y-8.205+5.429
5Y-8.20510Y-12.653+4.448
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.016-2.300+0.284
MRQ-1.952-2.656+0.704
TTM-2.776-2.718-0.058
YOY-5.078-4.145-0.933
5Y-8.205-6.258-1.947
10Y-12.653-6.315-6.338
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lexicon Pharmaceuticals Inc:

  • The EOD is -1.924. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.863. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.963. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.924MRQ-1.863-0.061
MRQ-1.863TTM-2.963+1.100
TTM-2.963YOY-5.729+2.766
TTM-2.9635Y-7.141+4.178
5Y-7.14110Y-11.110+3.969
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.924-2.974+1.050
MRQ-1.863-3.306+1.443
TTM-2.963-3.508+0.545
YOY-5.729-5.613-0.116
5Y-7.141-8.378+1.237
10Y-11.110-8.873-2.237
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lexicon Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.05 means the investor is paying $4.05 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Lexicon Pharmaceuticals Inc:

  • The EOD is 4.178. Based on the equity, the company is fair priced.
  • The MRQ is 4.046. Based on the equity, the company is fair priced.
  • The TTM is 3.948. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.178MRQ4.046+0.132
MRQ4.046TTM3.948+0.098
TTM3.948YOY5.034-1.086
TTM3.9485Y0.124+3.824
5Y0.12410Y-9.545+9.668
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.1781.914+2.264
MRQ4.0462.116+1.930
TTM3.9482.097+1.851
YOY5.0342.881+2.153
5Y0.1243.550-3.426
10Y-9.5453.936-13.481
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Lexicon Pharmaceuticals Inc.

3.1. Institutions holding Lexicon Pharmaceuticals Inc

Institutions are holding 82.155% of the shares of Lexicon Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Artal Group S A47.73995.979111755328400
2023-09-30Bvf Inc8.12040.58771999533200
2023-12-31BlackRock Inc2.84490.000370051533501875.262
2023-12-31Vanguard Group Inc2.42870.00025980371-419840-6.5598
2023-12-31JPMorgan Chase & Co1.23590.000530432912282578.1085
2023-12-31NEA Management Company, LLC0.96750.2429238228600
2023-12-31Geode Capital Management, LLC0.95390.0004234891622277910.4781
2023-12-31FMR Inc0.92450.00032276468-5286608-69.9002
2023-09-30Octagon Capital Advisors LP0.7810.322192307600
2023-12-31State Street Corporation0.76850.00011892319161800.8624
2023-12-31Ameriprise Financial Inc0.76760.0009189020067552255.6133
2023-12-31Pinnacle Associates Inc0.70290.04461730821-182048-9.517
2023-12-31Millennium Management LLC0.66330.00111633176-2252577-57.9702
2023-12-31Morgan Stanley - Brokerage Accounts0.37270.0001917688678068282.9764
2023-12-31Charles Schwab Investment Management Inc0.3510.0003864175122541.4384
2023-12-31Northern Trust Corp0.34910.0002859588-291229-25.3063
2023-09-30D. E. Shaw & Co LP0.31840.0009784122-429604-35.3955
2023-12-31GSA Capital Partners LLP0.31680.10047800777800770
2023-09-30Alyeska Investment Group, L.P.0.20690.0038509484-1232868-70.7588
2023-12-31Goldman Sachs Group Inc0.19110.000147067811096730.8489
Total 71.0057.2859174840505-7020483-4.0%

3.2. Funds holding Lexicon Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.50370.0006370277400
2024-03-28iShares Russell 2000 ETF0.93980.0085231419811160.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.72430.0044178342018031611.2479
2024-02-29JPMorgan Small Cap Value I0.55630.24851369696-95588-6.5235
2023-12-31Columbia Small Cap Value I0.49910.1377122894544027555.825
2024-02-29Columbia Small Cap Value I A0.49860.22971227645-9600-0.7759
2024-01-31CREF Stock R10.43870.00171080195885415454.5718
2024-01-31Fidelity Small Cap Index0.37960.0071934599227642.4965
2024-02-29Fidelity Extended Market Index0.27420.0044675278-3272-0.4822
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.23870.003558768200
2024-03-29Schwab US Small-Cap ETF™0.23140.00856978600
2024-01-31VALIC Company I Small Cap Value0.20490.1901504423-13173-2.545
2024-02-29Columbia VP Small Cap Value 10.19760.228548660800
2024-03-28iShares Russell 2000 Value ETF0.18920.0089465795-295-0.0633
2023-12-31BrighthouseI JPMorgan Small Cap Value A0.1590.151939161055401.435
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.14170.008634892200
2024-03-28iShares Russell 2000 Growth ETF0.14130.0072347818-404-0.116
2024-02-29Vanguard Russell 2000 ETF0.13510.0087332641263448.6008
2023-09-30BlackRock Extended Mkt Composite0.13030.00253208059759843.7253
2024-02-29AST Small Cap Value0.12660.0739311809-7399-2.3179
Total 7.71011.334418984649+1529637+8.1%

3.3. Insider Transactions

Insiders are holding 1.665% of the shares of Lexicon Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-16Lonnel CoatsBUY900001.05
2023-11-10Lonnel CoatsBUY100001.01
2023-10-12Raymond DebbaneBUY1488201.03
2023-10-10Raymond DebbaneBUY5083061.14
2023-09-14Jeffrey L WadeBUY100001.38
2023-08-04Wendy McdermottBUY60001.84
2023-06-29Lonnel CoatsBUY100002.16
2023-06-26Lonnel CoatsBUY100002.18
2023-06-23Wendy McdermottBUY100002.43
2023-06-22Lonnel CoatsBUY400002.31
2023-06-20Jeffrey L WadeBUY120002.33
2023-06-05International S.c.a. ArtalBUY277750502.6

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Lexicon Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.188-0.024-87%0.004-5359%0.024-876%-0.008-96%
Book Value Per Share--0.3780.515-27%0.431-12%0.392-4%0.474-20%
Current Ratio--5.5967.000-20%5.536+1%5.014+12%4.451+26%
Debt To Asset Ratio--0.5940.490+21%0.334+78%0.526+13%0.599-1%
Debt To Equity Ratio--1.4640.366+300%0.200+632%0.721+103%1.436+2%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Eps---0.196-0.178-9%-0.104-47%-0.060-70%-0.080-59%
Free Cash Flow Per Share---0.205-0.165-20%-0.092-55%-0.075-63%-0.078-62%
Free Cash Flow To Equity Per Share---0.2050.026-890%0.148-238%-0.015-93%-0.005-98%
Gross Profit Margin--1.0001.437-30%1.161-14%1.179-15%1.090-8%
Intrinsic Value_10Y_max---4.659--------
Intrinsic Value_10Y_min---6.545--------
Intrinsic Value_1Y_max---0.336--------
Intrinsic Value_1Y_min---0.498--------
Intrinsic Value_3Y_max---1.110--------
Intrinsic Value_3Y_min---1.641--------
Intrinsic Value_5Y_max---2.004--------
Intrinsic Value_5Y_min---2.935--------
Market Cap389054447.360+3%376742597.760451844880.320-17%508479388.480-26%771029581.200-51%1541253967.436-76%
Net Profit Margin---68.724-452.492+558%-765.019+1013%-429.950+526%-225.525+228%
Operating Margin---66.577-447.208+572%-747.836+1023%-425.436+539%-221.874+233%
Operating Ratio--67.577454.687-85%751.212-91%427.905-84%232.169-71%
Pb Ratio4.178+3%4.0463.948+2%5.034-20%0.124+3175%-9.545+336%
Pe Ratio-2.016-3%-1.952-2.776+42%-5.078+160%-8.205+320%-12.653+548%
Price Per Share1.580+3%1.5301.835-17%2.065-26%3.131-51%6.259-76%
Price To Free Cash Flow Ratio-1.924-3%-1.863-2.963+59%-5.729+207%-7.141+283%-11.110+496%
Price To Total Gains Ratio-8.385-3%-8.119-7.173-12%-13.756+69%-131.347+1518%-87.149+973%
Quick Ratio--10.09911.977-16%8.944+13%7.708+31%7.047+43%
Return On Assets---0.210-0.181-14%-0.170-19%-0.085-60%-0.080-62%
Return On Equity---0.518-0.130-75%-0.105-80%-0.037-93%-0.142-73%
Total Gains Per Share---0.188-0.024-87%0.004-5267%0.024-876%-0.008-96%
Usd Book Value--93110000.000126756750.000-27%106167500.000-12%96550750.000-4%116816900.000-20%
Usd Book Value Change Per Share---0.188-0.024-87%0.004-5359%0.024-876%-0.008-96%
Usd Book Value Per Share--0.3780.515-27%0.431-12%0.392-4%0.474-20%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Eps---0.196-0.178-9%-0.104-47%-0.060-70%-0.080-59%
Usd Free Cash Flow---50548000.000-40591750.000-20%-22544250.000-55%-18505050.000-63%-19303000.000-62%
Usd Free Cash Flow Per Share---0.205-0.165-20%-0.092-55%-0.075-63%-0.078-62%
Usd Free Cash Flow To Equity Per Share---0.2050.026-890%0.148-238%-0.015-93%-0.005-98%
Usd Market Cap389054447.360+3%376742597.760451844880.320-17%508479388.480-26%771029581.200-51%1541253967.436-76%
Usd Price Per Share1.580+3%1.5301.835-17%2.065-26%3.131-51%6.259-76%
Usd Profit---48244000.000-43644500.000-10%-25782000.000-47%-14695250.000-70%-19760850.000-59%
Usd Revenue--702000.000301250.000+133%34750.000+1920%17385500.000-96%18428425.000-96%
Usd Total Gains Per Share---0.188-0.024-87%0.004-5267%0.024-876%-0.008-96%
 EOD+5 -3MRQTTM+5 -29YOY+9 -275Y+7 -2910Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Lexicon Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.016
Price to Book Ratio (EOD)Between0-14.178
Net Profit Margin (MRQ)Greater than0-68.724
Operating Margin (MRQ)Greater than0-66.577
Quick Ratio (MRQ)Greater than110.099
Current Ratio (MRQ)Greater than15.596
Debt to Asset Ratio (MRQ)Less than10.594
Debt to Equity Ratio (MRQ)Less than11.464
Return on Equity (MRQ)Greater than0.15-0.518
Return on Assets (MRQ)Greater than0.05-0.210
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Lexicon Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.821
Ma 20Greater thanMa 501.867
Ma 50Greater thanMa 1002.229
Ma 100Greater thanMa 2001.929
OpenGreater thanClose1.550
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity -1,589,720-31,934-1,621,654-44,904-1,666,558-50,525-1,717,0831,810,19393,110
Accumulated Other Comprehensive Income  -428265-16363-100-13-11314431
Liabilities and Stockholders Equity  -1,512,545-34,439-1,546,98410,789-1,536,195-43,919-1,580,1141,809,543229,429



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets229,429
Total Liabilities136,319
Total Stockholder Equity93,110
 As reported
Total Liabilities 136,319
Total Stockholder Equity+ 93,110
Total Assets = 229,429

Assets

Total Assets229,429
Total Current Assets176,547
Long-term Assets52,882
Total Current Assets
Cash And Cash Equivalents 22,465
Short-term Investments 147,561
Net Receivables 1,010
Inventory 381
Other Current Assets 5,130
Total Current Assets  (as reported)176,547
Total Current Assets  (calculated)176,547
+/-0
Long-term Assets
Property Plant Equipment 7,511
Goodwill 44,543
Long-term Assets Other 828
Long-term Assets  (as reported)52,882
Long-term Assets  (calculated)52,882
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities31,546
Long-term Liabilities104,773
Total Stockholder Equity93,110
Total Current Liabilities
Short-term Debt 1,291
Accounts payable 14,389
Other Current Liabilities 15,866
Total Current Liabilities  (as reported)31,546
Total Current Liabilities  (calculated)31,546
+/-0
Long-term Liabilities
Long term Debt 99,508
Capital Lease Obligations Min Short Term Debt5,265
Long-term Liabilities  (as reported)104,773
Long-term Liabilities  (calculated)104,773
+/-0
Total Stockholder Equity
Common Stock245
Retained Earnings -1,766,839
Accumulated Other Comprehensive Income 31
Other Stockholders Equity 1,859,673
Total Stockholder Equity (as reported)93,110
Total Stockholder Equity (calculated)93,110
+/-0
Other
Capital Stock245
Cash and Short Term Investments 170,026
Common Stock Shares Outstanding 244,925
Liabilities and Stockholders Equity 229,429
Net Debt 83,599
Net Invested Capital 192,618
Net Working Capital 145,001
Property Plant and Equipment Gross 12,049
Short Long Term Debt Total 106,064



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
20,920
222,044
221,111
220,693
214,893
221,998
249,680
239,990
226,523
213,835
198,889
201,772
181,967
173,394
209,387
284,199
262,936
221,179
215,132
211,980
188,908
192,149
208,967
218,714
203,301
182,671
165,348
190,266
167,368
200,962
378,192
369,296
336,573
310,306
283,703
261,508
244,452
244,333
223,684
257,761
409,211
365,155
370,873
366,884
343,408
315,916
294,706
430,512
402,792
381,060
357,835
371,778
347,275
323,393
299,458
274,160
243,600
224,064
187,522
471,376
444,682
415,964
391,140
654,832
611,341
558,134
516,945
475,625
396,264
363,513
329,487
436,539
386,813
332,937
310,192
284,136
258,516
233,143
444,588
417,715
370,567
322,540
178,928
203,788
193,260
171,672
172,330
136,909
136,178
112,325
191,685
194,299
162,716
316,724
276,479
229,429
229,429276,479316,724162,716194,299191,685112,325136,178136,909172,330171,672193,260203,788178,928322,540370,567417,715444,588233,143258,516284,136310,192332,937386,813436,539329,487363,513396,264475,625516,945558,134611,341654,832391,140415,964444,682471,376187,522224,064243,600274,160299,458323,393347,275371,778357,835381,060402,792430,512294,706315,916343,408366,884370,873365,155409,211257,761223,684244,333244,452261,508283,703310,306336,573369,296378,192200,962167,368190,266165,348182,671203,301218,714208,967192,149188,908211,980215,132221,179262,936284,199209,387173,394181,967201,772198,889213,835226,523239,990249,680221,998214,893220,693221,111222,04420,920
   > Total Current Assets 
10,243
212,163
208,736
206,032
198,346
203,517
190,287
166,442
149,089
139,548
124,520
133,132
115,986
109,341
146,643
171,505
152,050
110,053
103,705
98,748
75,570
78,114
95,372
106,047
92,580
73,862
58,437
85,552
64,777
100,281
279,402
264,650
174,375
152,950
131,425
109,167
94,215
95,952
133,710
169,684
321,907
282,453
235,617
214,738
193,189
169,193
148,981
285,790
258,985
231,513
206,848
230,935
206,464
183,076
159,362
134,554
105,408
86,667
87,820
368,987
342,310
313,799
288,947
532,400
492,158
439,454
398,737
357,874
279,088
247,186
214,021
321,995
273,150
220,191
198,360
173,324
146,827
122,459
363,594
337,754
291,614
246,192
121,938
157,719
145,416
123,258
124,005
88,921
88,431
64,898
139,063
140,866
109,546
263,720
223,372
176,547
176,547223,372263,720109,546140,866139,06364,89888,43188,921124,005123,258145,416157,719121,938246,192291,614337,754363,594122,459146,827173,324198,360220,191273,150321,995214,021247,186279,088357,874398,737439,454492,158532,400288,947313,799342,310368,98787,82086,667105,408134,554159,362183,076206,464230,935206,848231,513258,985285,790148,981169,193193,189214,738235,617282,453321,907169,684133,71095,95294,215109,167131,425152,950174,375264,650279,402100,28164,77785,55258,43773,86292,580106,04795,37278,11475,57098,748103,705110,053152,050171,505146,643109,341115,986133,132124,520139,548149,089166,442190,287203,517198,346206,032208,736212,16310,243
       Cash And Cash Equivalents 
1,703
49,633
23,942
37,811
79,219
43,585
23,067
23,048
47,542
22,297
79,724
39,362
39,177
33,895
64,271
81,915
51,192
67,092
67,115
14,612
12,809
12,490
23,120
21,970
21,858
14,542
12,118
30,226
19,608
22,587
50,721
22,938
59,457
109,649
100,209
85,873
16,953
49,166
62,736
100,554
260,126
247,698
211,988
47,208
20,118
20,328
30,521
186,309
29,010
33,779
20,759
223,208
34,248
175,378
19,581
129,128
46,517
79,044
57,869
339,339
315,097
9,744
256,422
521,352
477,146
38,410
395,556
346,504
259,743
30,706
83,293
310,788
20,421
15,044
48,902
160,052
45,778
105,977
170,203
36,112
55,592
86,943
52,251
126,263
97,652
118,501
92,118
64,065
59,520
21,450
18,834
46,345
26,001
102,271
21,116
22,465
22,46521,116102,27126,00146,34518,83421,45059,52064,06592,118118,50197,652126,26352,25186,94355,59236,112170,203105,97745,778160,05248,90215,04420,421310,78883,29330,706259,743346,504395,55638,410477,146521,352256,4229,744315,097339,33957,86979,04446,517129,12819,581175,37834,248223,20820,75933,77929,010186,30930,52120,32820,11847,208211,988247,698260,126100,55462,73649,16616,95385,873100,209109,64959,45722,93850,72122,58719,60830,22612,11814,54221,85821,97023,12012,49012,80914,61267,11567,09251,19281,91564,27133,89539,17739,36279,72422,29747,54223,04823,06743,58579,21937,81123,94249,6331,703
       Short-term Investments 
6,927
161,009
182,381
164,869
112,935
140,224
153,361
133,394
91,203
73,082
34,158
54,247
23,579
4,584
12,316
22,123
37,270
37,218
30,556
72,946
57,930
60,302
67,121
77,725
65,126
50,785
40,905
49,773
39,910
72,645
223,194
235,837
110,051
34,308
23,377
17,239
72,311
38,239
62,410
61,959
54,055
24,083
19,030
163,903
168,792
144,486
113,634
95,383
224,646
197,734
186,089
192,785
162,915
152,124
131,629
91,629
51,850
51,319
31,094
202,073
273,137
272,739
194,748
318,363
452,465
390,955
356,784
299,904
257,288
200,481
113,524
249,127
241,851
194,645
138,395
79,666
87,367
94,871
126,101
235,547
193,545
114,923
59,195
26,012
43,709
28,614
28,800
22,678
26,982
40,518
117,369
92,012
79,936
154,468
197,311
147,561
147,561197,311154,46879,93692,012117,36940,51826,98222,67828,80028,61443,70926,01259,195114,923193,545235,547126,10194,87187,36779,666138,395194,645241,851249,127113,524200,481257,288299,904356,784390,955452,465318,363194,748272,739273,137202,07331,09451,31951,85091,629131,629152,124162,915192,785186,089197,734224,64695,383113,634144,486168,792163,90319,03024,08354,05561,95962,41038,23972,31117,23923,37734,308110,051235,837223,19472,64539,91049,77340,90550,78565,12677,72567,12160,30257,93072,94630,55637,21837,27022,12312,3164,58423,57954,24734,15873,08291,203133,394153,361140,224112,935164,869182,381161,0096,927
       Net Receivables 
1,554
1,484
2,364
2,815
3,748
16,038
7,997
4,544
4,282
4,043
4,993
5,143
3,809
9,062
8,917
6,571
3,181
2,178
2,013
6,397
1,747
1,789
1,698
2,608
2,158
4,896
2,064
1,186
1,722
1,357
1,747
1,763
1,244
672
770
568
1,248
530
1,347
815
1,969
2,083
1,340
744
831
505
489
350
186
182
233
1,378
863
1,014
895
790
471
281
165
1,035
170
316
72
911
741
1,018
738
7,492
8,733
5,014
10,597
4,825
4,482
4,406
2,913
5,924
4,390
5,580
56,841
56,532
30,135
30,876
1,383
395
101
159
23
14
37
34
39
28
261
685
318
1,010
1,0103186852612839343714231591013951,38330,87630,13556,53256,8415,5804,3905,9242,9134,4064,4824,82510,5975,0148,7337,4927381,018741911723161701,0351652814717908951,0148631,3782331821863504895058317441,3402,0831,9698151,3475301,2485687706721,2441,7631,7471,3571,7221,1862,0644,8962,1582,6081,6981,7891,7476,3972,0132,1783,1816,5718,9179,0623,8095,1434,9934,0434,2824,5447,99716,0383,7482,8152,3641,4841,554
       Other Current Assets 
59
37
49
536
2,445
3,669
5,862
5,456
6,062
40,126
5,645
34,380
49,421
61,800
61,139
60,896
60,407
3,565
4,021
4,793
3,084
3,533
3,433
3,744
3,438
3,639
3,350
4,367
3,537
3,692
3,740
4,112
3,623
8,321
7,069
5,487
3,703
8,017
7,217
6,356
5,757
8,589
3,259
2,883
3,448
3,874
4,337
3,748
5,143
6,582
9,004
6,349
8,438
6,684
7,257
4,636
6,570
7,342
29,786
23,849
23,849
23,849
21,500
10,137
14,271
9,071
2,443
3,878
10,376
10,174
4,458
4,434
4,284
3,954
3,395
2,668
4,686
6,625
5,973
5,320
8,195
9,461
9,109
5,049
3,954
4,598
3,064
2,164
1,892
2,896
2,821
2,481
3,348
6,124
4,291
5,130
5,1304,2916,1243,3482,4812,8212,8961,8922,1643,0644,5983,9545,0499,1099,4618,1955,3205,9736,6254,6862,6683,3953,9544,2844,4344,45810,17410,3763,8782,4439,07114,27110,13721,50023,84923,84923,84929,7867,3426,5704,6367,2576,6848,4386,3499,0046,5825,1433,7484,3373,8743,4482,8833,2598,5895,7576,3567,2178,0173,7035,4877,0698,3213,6234,1123,7403,6923,5374,3673,3503,6393,4383,7443,4333,5333,0844,7934,0213,56560,40760,89661,13961,80049,42134,3805,64540,1266,0625,4565,8623,6692,445536493759
   > Long-term Assets 
10,677
9,881
12,375
14,661
16,547
18,482
59,393
73,548
77,434
74,287
74,369
68,640
65,981
64,053
62,744
112,694
110,886
111,126
111,427
113,232
113,338
114,035
113,595
112,667
110,721
108,809
106,911
104,714
102,591
100,681
98,790
104,646
162,198
157,356
152,278
152,341
150,237
148,381
89,974
88,077
87,304
82,702
135,256
152,146
150,219
146,723
145,725
144,722
143,807
149,547
150,987
140,843
140,811
140,317
140,096
139,606
138,192
137,397
99,702
102,389
102,372
102,165
102,193
122,432
119,183
118,680
118,208
117,751
117,176
116,327
115,466
114,544
113,663
112,746
111,832
110,812
111,689
110,684
80,994
79,961
78,953
76,348
56,990
46,069
47,844
48,414
48,325
47,988
47,747
47,427
52,622
53,433
53,170
53,004
53,107
52,882
52,88253,10753,00453,17053,43352,62247,42747,74747,98848,32548,41447,84446,06956,99076,34878,95379,96180,994110,684111,689110,812111,832112,746113,663114,544115,466116,327117,176117,751118,208118,680119,183122,432102,193102,165102,372102,38999,702137,397138,192139,606140,096140,317140,811140,843150,987149,547143,807144,722145,725146,723150,219152,146135,25682,70287,30488,07789,974148,381150,237152,341152,278157,356162,198104,64698,790100,681102,591104,714106,911108,809110,721112,667113,595114,035113,338113,232111,427111,126110,886112,69462,74464,05365,98168,64074,36974,28777,43473,54859,39318,48216,54714,66112,3759,88110,677
       Property Plant Equipment 
9,287
9,587
11,700
14,477
16,019
16,856
22,726
26,707
33,522
35,571
35,990
37,362
35,516
34,401
33,430
83,676
82,146
81,810
82,439
84,573
85,026
86,051
85,996
85,265
83,775
82,174
80,351
78,192
76,041
74,214
72,350
70,829
69,650
68,104
66,444
65,087
63,027
61,526
60,090
58,754
57,850
56,552
55,404
53,427
51,815
48,370
47,344
46,417
45,526
44,526
43,515
42,634
42,623
42,152
41,838
41,362
39,959
39,177
1,494
1,080
732
684
795
21,227
20,753
20,350
19,854
19,390
18,995
18,588
18,167
17,687
17,244
16,772
16,299
15,865
15,475
15,007
14,540
14,047
13,582
11,524
11,106
295
296
1,201
1,311
1,176
1,142
1,035
932
2,071
2,207
8,461
2,134
7,511
7,5112,1348,4612,2072,0719321,0351,1421,1761,3111,20129629511,10611,52413,58214,04714,54015,00715,47515,86516,29916,77217,24417,68718,16718,58818,99519,39019,85420,35020,75321,2277956847321,0801,49439,17739,95941,36241,83842,15242,62342,63443,51544,52645,52646,41747,34448,37051,81553,42755,40456,55257,85058,75460,09061,52663,02765,08766,44468,10469,65070,82972,35074,21476,04178,19280,35182,17483,77585,26585,99686,05185,02684,57382,43981,81082,14683,67633,43034,40135,51637,36235,99035,57133,52226,70722,72616,85616,01914,47711,7009,5879,287
       Goodwill 
0
0
0
0
0
0
0
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,543
44,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54344,54325,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,7980000000
       Intangible Assets 
0
0
0
0
0
0
31,521
5,440
30,938
30,638
30,338
30,038
29,738
29,438
29,138
28,838
28,538
28,238
27,938
27,638
27,338
27,038
26,738
26,438
340
40
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
25,798
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,557
53,357
53,357
53,357
53,357
53,357
53,357
53,357
53,357
53,357
53,210
52,768
52,327
51,885
51,444
51,002
50,561
50,119
49,678
49,236
20,157
19,716
19,275
18,833
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000018,83319,27519,71620,15749,23649,67850,11950,56151,00251,44451,88552,32752,76853,21053,35753,35753,35753,35753,35753,35753,35753,35753,35753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55753,55725,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,79825,7984034026,43826,73827,03827,33827,63827,93828,23828,53828,83829,13829,43829,73830,03830,33830,63830,9385,44031,521000000
       Long-term Assets Other 
1,391
294
676
184
527
1,625
5,147
15,603
12,974
8,078
8,041
1,240
727
214
176
180
202
1,078
1,050
1,021
974
946
861
964
808
797
762
724
752
669
642
8,019
66,750
63,454
60,036
61,456
5,209
4,648
4,086
3,525
3,656
352
497
619
304
253
281
205
181
6,921
9,372
109
88
65
158
144
133
120
108
3,409
3,740
3,581
3,498
3,305
530
430
454
461
428
428
429
429
432
429
429
285
1,993
1,898
1,754
1,655
1,553
1,448
1,341
1,231
3,005
2,670
2,471
2,269
2,062
1,849
7,147
6,819
6,420
-53,004
6,430
828
8286,430-53,0046,4206,8197,1471,8492,0622,2692,4712,6703,0051,2311,3411,4481,5531,6551,7541,8981,9932854294294324294294284284614544305303,3053,4983,5813,7403,40910812013314415865881099,3726,9211812052812533046194973523,6563,5254,0864,6485,20961,45660,03663,45466,7508,0196426697527247627978089648619469741,0211,0501,0782021801762147271,2408,0418,07812,97415,6035,1471,6255271846762941,391
> Total Liabilities 
14,093
11,974
8,919
13,064
12,352
26,448
22,724
21,618
19,753
18,708
17,886
31,870
26,646
33,072
30,901
117,983
110,154
84,878
93,142
90,386
80,509
98,247
129,113
132,912
126,369
120,816
110,698
104,765
98,364
91,119
86,823
82,725
73,425
72,650
69,762
65,681
71,160
93,223
93,785
94,264
90,306
70,120
102,019
119,860
124,091
121,728
125,225
132,944
133,821
136,164
105,076
105,100
105,067
108,309
113,748
103,997
102,825
107,396
109,698
187,358
187,075
184,490
193,202
368,982
358,460
340,801
331,764
318,224
261,661
257,200
251,111
384,437
360,619
338,008
339,593
310,541
304,203
298,029
279,876
300,614
315,790
333,227
91,289
47,417
40,713
34,439
35,727
23,314
43,480
41,495
47,667
77,175
74,670
130,363
136,969
136,319
136,319136,969130,36374,67077,17547,66741,49543,48023,31435,72734,43940,71347,41791,289333,227315,790300,614279,876298,029304,203310,541339,593338,008360,619384,437251,111257,200261,661318,224331,764340,801358,460368,982193,202184,490187,075187,358109,698107,396102,825103,997113,748108,309105,067105,100105,076136,164133,821132,944125,225121,728124,091119,860102,01970,12090,30694,26493,78593,22371,16065,68169,76272,65073,42582,72586,82391,11998,364104,765110,698120,816126,369132,912129,11398,24780,50990,38693,14284,878110,154117,98330,90133,07226,64631,87017,88618,70819,75321,61822,72426,44812,35213,0648,91911,97414,093
   > Total Current Liabilities 
10,785
9,554
6,709
11,231
10,773
21,448
18,915
18,779
18,174
18,388
17,346
21,299
16,789
23,940
22,650
31,766
27,527
27,361
32,132
38,710
32,948
38,636
48,319
57,463
55,487
54,491
48,216
45,966
43,162
39,495
37,345
35,347
27,691
27,656
25,007
21,176
12,282
12,351
50,166
50,954
47,316
27,446
12,948
10,775
14,480
13,226
14,806
21,390
20,933
38,519
38,157
18,285
17,381
40,903
23,598
19,294
17,673
21,896
44,269
44,969
45,933
43,571
51,799
122,996
121,943
130,992
170,113
164,643
137,061
133,173
128,728
124,127
100,370
81,336
68,506
36,751
28,221
22,469
44,824
65,341
80,319
97,558
78,922
46,806
38,995
32,815
34,246
22,124
18,905
16,862
18,445
23,172
20,371
26,109
32,261
31,546
31,54632,26126,10920,37123,17218,44516,86218,90522,12434,24632,81538,99546,80678,92297,55880,31965,34144,82422,46928,22136,75168,50681,336100,370124,127128,728133,173137,061164,643170,113130,992121,943122,99651,79943,57145,93344,96944,26921,89617,67319,29423,59840,90317,38118,28538,15738,51920,93321,39014,80613,22614,48010,77512,94827,44647,31650,95450,16612,35112,28221,17625,00727,65627,69135,34737,34539,49543,16245,96648,21654,49155,48757,46348,31938,63632,94838,71032,13227,36127,52731,76622,65023,94016,78921,29917,34618,38818,17418,77918,91521,44810,77311,2316,7099,55410,785
       Short-term Debt 
1,158
901
874
1,012
1,030
974
11,183
0
0
0
0
0
0
0
0
0
0
663
677
4,691
4,705
4,721
4,736
4,751
4,767
4,783
4,800
816
826
844
861
880
905
924
944
963
984
1,004
38,860
38,482
36,599
17,100
1,114
1,138
1,155
1,380
1,413
1,443
1,478
24,188
23,826
1,574
1,607
22,678
1,675
1,710
1,746
1,783
20,609
20,167
19,711
19,255
18,788
2,015
2,020
17,289
16,792
16,280
15,753
15,156
14,633
14,094
13,517
12,896
1,115
1,115
1,115
1,115
11,289
11,012
10,734
11,010
9,244
12,199
12,686
12,702
12,720
1,089
940
789
1,406
1,291
1,291
1,291
1,291
1,291
1,2911,2911,2911,2911,2911,4067899401,08912,72012,70212,68612,1999,24411,01010,73411,01211,2891,1151,1151,1151,11512,89613,51714,09414,63315,15615,75316,28016,79217,2892,0202,01518,78819,25519,71120,16720,6091,7831,7461,7101,67522,6781,6071,57423,82624,1881,4781,4431,4131,3801,1551,1381,11417,10036,59938,48238,8601,0049849639449249058808618448268164,8004,7834,7674,7514,7364,7214,7054,691677663000000000011,1839741,0301,0128749011,158
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,167
0
0
0
1,976
2,020
17,289
16,792
16,280
101,021
100,539
14,633
14,094
13,517
12,896
1,115
1,115
1,115
1,115
11,289
11,012
10,734
10,457
8,691
11,646
11,660
11,675
11,693
0
0
0
0
0
0
0
0
0
00000000011,69311,67511,66011,6468,69110,45710,73411,01211,2891,1151,1151,1151,11512,89613,51714,09414,633100,539101,02116,28016,79217,2892,0201,97600020,16700000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,970
1,667
2,328
5,546
3,136
6,458
4,126
3,168
4,046
4,406
4,270
4,378
2,752
4,078
3,959
5,884
3,820
3,739
3,929
7,574
3,495
2,802
3,751
6,883
3,589
4,326
4,269
6,513
4,366
4,701
4,913
7,344
4,252
7,920
8,055
7,926
3,083
3,210
3,413
5,919
4,773
3,547
3,550
3,159
5,452
3,671
5,526
6,042
5,324
4,579
4,306
7,661
5,442
6,281
9,709
9,715
7,072
8,350
9,741
13,064
12,142
11,291
16,355
19,725
25,544
28,225
41,545
52,877
41,945
43,857
52,628
57,652
66,553
50,451
51,480
17,759
13,874
10,028
20,907
12,178
18,236
29,763
11,734
5,469
4,926
8,545
8,345
9,152
9,321
7,347
9,427
10,395
10,311
10,501
12,036
14,389
14,38912,03610,50110,31110,3959,4277,3479,3219,1528,3458,5454,9265,46911,73429,76318,23612,17820,90710,02813,87417,75951,48050,45166,55357,65252,62843,85741,94552,87741,54528,22525,54419,72516,35511,29112,14213,0649,7418,3507,0729,7159,7096,2815,4427,6614,3064,5795,3246,0425,5263,6715,4523,1593,5503,5474,7735,9193,4133,2103,0837,9268,0557,9204,2527,3444,9134,7014,3666,5134,2694,3263,5896,8833,7512,8023,4957,5743,9293,7393,8205,8843,9594,0782,7524,3784,2704,4064,0463,1684,1266,4583,1365,5462,3281,6671,970
       Other Current Liabilities 
7,657
6,986
3,506
4,672
1,763
1,974
3,606
5,016
4,035
4,565
4,782
4,161
3,534
7,211
7,862
4,757
3,811
5,327
6,691
6,945
5,682
7,295
8,032
6,787
6,857
8,054
9,525
7,325
6,772
7,556
8,593
9,093
9,393
8,489
9,338
6,615
5,106
6,863
6,812
5,611
5,368
6,285
7,437
6,264
7,688
8,037
7,703
13,786
13,710
-4,579
-4,306
8,922
9,704
11,321
11,529
7,674
7,952
10,886
13,134
10,120
11,769
10,807
14,913
24,757
23,615
23,950
32,906
32,114
10,191
10,959
12,729
12,282
12,863
12,865
13,794
14,482
10,800
9,083
11,511
42,151
51,349
2,367
1,704
976
1,326
1,155
13,181
12,972
8,644
8,726
7,612
11,486
8,769
15,608
20,225
15,866
15,86620,22515,6088,76911,4867,6128,7268,64412,97213,1811,1551,3269761,7042,36751,34942,15111,5119,08310,80014,48213,79412,86512,86312,28212,72910,95910,19132,11432,90623,95023,61524,75714,91310,80711,76910,12013,13410,8867,9527,67411,52911,3219,7048,922-4,306-4,57913,71013,7867,7038,0377,6886,2647,4376,2855,3685,6116,8126,8635,1066,6159,3388,4899,3939,0938,5937,5566,7727,3259,5258,0546,8576,7878,0327,2955,6826,9456,6915,3273,8114,7577,8627,2113,5344,1614,7824,5654,0355,0163,6061,9741,7634,6723,5066,9867,657
   > Long-term Liabilities 
3,309
2,420
2,210
1,834
1,579
5,000
3,809
2,839
1,579
320
540
10,571
9,857
9,132
8,251
86,217
82,627
57,517
61,010
51,676
47,561
59,611
80,794
75,449
70,882
66,325
62,482
58,799
55,202
51,624
49,478
47,378
45,734
44,994
44,755
44,505
58,878
80,872
43,619
43,310
42,990
42,674
89,071
109,085
109,611
108,502
110,419
111,554
112,888
97,645
66,919
86,815
87,686
67,406
90,150
84,703
85,152
85,500
65,429
142,389
141,142
140,919
141,403
245,986
236,517
209,809
161,651
153,581
124,600
124,027
122,383
260,310
260,249
256,672
271,087
273,790
275,982
275,560
235,052
235,273
235,471
235,669
12,367
611
1,718
1,624
1,481
1,190
24,575
24,633
29,222
54,003
54,299
104,254
104,708
104,773
104,773104,708104,25454,29954,00329,22224,63324,5751,1901,4811,6241,71861112,367235,669235,471235,273235,052275,560275,982273,790271,087256,672260,249260,310122,383124,027124,600153,581161,651209,809236,517245,986141,403140,919141,142142,38965,42985,50085,15284,70390,15067,40687,68686,81566,91997,645112,888111,554110,419108,502109,611109,08589,07142,67442,99043,31043,61980,87258,87844,50544,75544,99445,73447,37849,47851,62455,20258,79962,48266,32570,88275,44980,79459,61147,56151,67661,01057,51782,62786,2178,2519,1329,85710,5715403201,5792,8393,8095,0001,5791,8342,2102,4203,309
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,188
23,826
23,451
23,063
22,678
22,284
21,877
21,457
0
20,609
20,167
19,711
19,255
0
87,500
87,500
87,500
87,500
103,793
100,550
84,909
85,038
85,167
85,268
85,383
85,512
231,576
231,879
232,198
243,830
243,887
243,912
243,953
233,837
234,171
234,488
234,807
11,629
0
0
0
0
0
23,477
23,631
23,784
0
48,845
0
0
0
00048,845023,78423,63123,4770000011,629234,807234,488234,171233,837243,953243,912243,887243,830232,198231,879231,57685,51285,38385,26885,16785,03884,909100,550103,79387,50087,50087,50087,500019,25519,71120,16720,609021,45721,87722,28422,67823,06323,45123,82624,188000000000000000000000000000000000000000000000
       Long term Debt 
3,308
2,420
2,210
1,834
1,579
0
59
0
0
0
0
4,000
4,000
4,000
4,000
56,344
56,344
37,289
37,120
32,940
32,748
32,568
32,384
32,189
31,982
31,785
31,584
31,372
31,156
30,942
30,723
30,493
30,251
30,018
29,779
29,529
43,939
65,970
28,754
28,482
28,199
27,922
27,640
27,345
27,044
24,188
23,826
23,451
23,063
22,678
22,284
21,877
21,457
0
20,609
20,167
19,711
19,255
0
87,500
87,500
87,500
87,500
103,793
100,550
84,909
85,038
85,167
85,268
85,383
85,512
231,576
231,879
232,198
243,830
243,887
243,912
243,953
233,837
234,171
234,488
234,807
11,629
0
0
0
0
0
23,477
23,631
23,784
48,579
48,845
98,772
99,265
99,508
99,50899,26598,77248,84548,57923,78423,63123,4770000011,629234,807234,488234,171233,837243,953243,912243,887243,830232,198231,879231,57685,51285,38385,26885,16785,03884,909100,550103,79387,50087,50087,50087,500019,25519,71120,16720,609021,45721,87722,28422,67823,06323,45123,82624,18827,04427,34527,64027,92228,19928,48228,75465,97043,93929,52929,77930,01830,25130,49330,72330,94231,15631,37231,58431,78531,98232,18932,38432,56832,74832,94037,12037,28956,34456,3444,0004,0004,0004,00000005901,5791,8342,2102,4203,308
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,102
0
553
553
1,164
1,026
1,027
2,508
2,279
2,038
1,791
6,844
6,715
6,745
6,773
6,734
6,556
6,5566,7346,7736,7456,7156,8441,7912,0382,2792,5081,0271,0261,16455355301,1020000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
5,000
3,750
2,839
1,579
320
540
6,571
5,857
5,132
4,251
29,873
26,283
20,228
23,890
18,736
14,813
27,043
48,410
43,260
38,900
34,540
30,898
27,427
24,046
20,682
18,755
16,885
15,483
14,976
14,976
14,976
14,939
14,902
14,865
14,828
14,791
14,752
61,431
62,995
63,822
65,569
67,848
69,358
71,080
73,186
44,996
46,193
47,484
48,661
50,796
45,791
46,696
47,500
46,684
36,214
34,967
34,744
35,228
123,518
117,292
106,225
57,938
49,739
29,309
28,621
26,848
22,720
28,370
24,474
27,257
29,903
30,637
30,282
34,750
55,431
70,568
862
0
35,771
1
22,764
24,034
23,314
0
17,864
5,438
0
0
0
0
0
000005,43817,864023,31424,03422,764135,771086270,56855,43134,75030,28230,63729,90327,25724,47428,37022,72026,84828,62129,30949,73957,938106,225117,292123,51835,22834,74434,96736,21446,68447,50046,69645,79150,79648,66147,48446,19344,99673,18671,08069,35867,84865,56963,82262,99561,43114,75214,79114,82814,86514,90214,93914,97614,97614,97615,48316,88518,75520,68224,04627,42730,89834,54038,90043,26048,41027,04314,81318,73623,89020,22826,28329,8734,2515,1325,8576,5715403201,5792,8393,7505,00000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,357
53,636
55,146
57,170
59,276
31,086
32,283
34,079
35,256
37,391
32,386
34,017
34,821
34,005
23,535
23,259
23,036
23,520
14,367
14,593
14,037
2,500
805
559
313
303
292
279
265
252
238
1,433
1,325
1,215
1,102
983
862
738
611
1,718
1,624
1,481
1,190
1,098
1,002
5,438
5,424
5,454
5,482
0
0
005,4825,4545,4245,4381,0021,0981,1901,4811,6241,7186117388629831,1021,2151,3251,4332382522652792923033135598052,50014,03714,59314,36723,52023,03623,25923,53534,00534,82134,01732,38637,39135,25634,07932,28331,08659,27657,17055,14653,63651,357000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,957
32,957
32,957
32,655
32,655
32,655
32,655
32,150
32,150
32,150
32,150
31,424
31,424
31,424
31,354
30,383
30,383
30,383
127,826
121,374
110,863
74,113
67,609
38,773
38,331
36,568
28,442
28,091
24,209
27,005
29,665
30,637
30,282
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000030,28230,63729,66527,00524,20928,09128,44236,56838,33138,77367,60974,113110,863121,374127,82630,38330,38330,38331,35431,42431,42431,42432,15032,15032,15032,15032,65532,65532,65532,65532,95732,95732,957000000000000000000000000000000000000000000000
> Total Stockholder Equity
6,827
210,070
212,192
207,628
202,541
195,550
226,956
218,372
206,770
195,127
181,003
169,902
155,321
140,322
178,486
166,216
152,782
136,301
121,990
121,594
108,399
93,902
79,854
85,802
76,932
61,855
54,650
85,501
69,004
79,935
265,389
256,300
237,801
218,457
199,681
185,580
165,822
147,109
129,424
163,787
318,905
295,035
268,854
247,024
219,317
194,188
169,481
297,568
268,971
244,896
252,759
266,678
242,208
215,084
185,710
-1,003,959
140,775
116,668
77,824
284,018
257,607
231,474
197,938
285,850
252,881
217,333
185,181
157,401
134,603
106,313
78,376
52,102
26,194
-5,071
-29,401
-26,405
-45,687
-64,886
164,712
117,101
54,777
-10,687
87,639
156,371
152,547
137,233
136,603
-1,487,776
92,698
-1,535,839
144,018
-1,589,720
-1,621,654
-1,666,558
-1,717,083
93,110
93,110-1,717,083-1,666,558-1,621,654-1,589,720144,018-1,535,83992,698-1,487,776136,603137,233152,547156,37187,639-10,68754,777117,101164,712-64,886-45,687-26,405-29,401-5,07126,19452,10278,376106,313134,603157,401185,181217,333252,881285,850197,938231,474257,607284,01877,824116,668140,775-1,003,959185,710215,084242,208266,678252,759244,896268,971297,568169,481194,188219,317247,024268,854295,035318,905163,787129,424147,109165,822185,580199,681218,457237,801256,300265,38979,93569,00485,50154,65061,85576,93285,80279,85493,902108,399121,594121,990136,301152,782166,216178,486140,322155,321169,902181,003195,127206,770218,372226,956195,550202,541207,628212,192210,0706,827
   Common Stock
25
48
48
48
49
49
52
52
52
52
52
52
52
52
63
63
63
63
63
63
63
64
64
64
65
65
66
78
78
86
137
137
137
137
137
137
137
137
137
176
338
338
338
338
338
338
338
480
481
481
495
512
514
514
514
514
516
516
516
726
727
104
104
104
104
104
104
105
105
105
106
106
106
106
106
106
106
106
106
106
108
108
117
142
145
146
150
150
150
150
189
189
190
245
245
245
245245245190189189150150150150146145142117108108106106106106106106106106106106105105105104104104104104104727726516516516514514514514512495481481480338338338338338338338176137137137137137137137137137867878666565646464636363636363635252525252525252494948484825
   Retained Earnings Total Equity00-1,666,558-1,621,654-1,589,720-1,559,226-1,535,839-1,511,252-1,487,776-1,462,165-1,439,043-1,420,976-1,400,018-1,394,523-1,477,126-1,408,055-1,341,444-1,290,306-1,516,392-1,493,374-1,471,577-1,471,485-1,443,973-1,409,267-1,381,404-1,353,026-1,322,304-1,287,245-1,250,363-1,217,944-1,181,929-1,143,817-1,108,934-1,195,684-1,160,402-1,132,328-1,104,252-1,101,319-1,060,821-1,034,793-1,003,958-986,544-954,886-925,806-899,832-874,959-845,420-819,489-789,621-755,776-729,673000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-49,486
-46,252
-36,472
-33,637
-30,566
-27,853
-24,937
-22,697
-20,121
-16,648
-13,811
-11,106
-8,507
-5,988
-3,387
-899
-61
-52
-24
-20
-40
-26
-59
-54
-52
-42
-4
-16
-7
-9
-162
-4
-2,332
-3,225
38
-71,102
-5
-1
-1
-75,795
-76,015
-77,192
-1
5
40
71
34
21
-57
-20
21
23
42
31
38
2
10
5
2
-63
23
98
58
-219
297
336
78
-195
-264
-214
-63
-222
-394
-218
-71
-12
33
86
36
84
860
312
35
-6
5
-5
-6
-10
-37
-150
-491
-428
-163
-100
-113
31
31-113-100-163-428-491-150-37-10-6-55-63531286084368633-12-71-218-394-222-63-214-264-19578336297-219589823-63251023831422321-20-57213471405-1-77,192-76,015-75,795-1-1-5-71,10238-3,225-2,332-4-162-9-7-16-4-42-52-54-59-26-40-20-24-52-61-899-3,387-5,988-8,507-11,106-13,811-16,648-20,121-22,697-24,937-27,853-30,566-33,637-36,472-46,252-49,486
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
923,797
925,230
1,087,033
1,088,666
1,090,485
1,127,832
1,166,605
1,168,961
1,170,928
1,173,205
1,175,108
1,177,432
1,179,358
1,181,015
1,389,997
1,391,932
1,394,421
1,396,207
1,397,646
1,399,665
1,402,190
1,406,311
1,411,222
1,423,911
1,430,630
1,433,263
1,435,526
1,438,625
1,441,890
1,444,925
1,447,954
1,451,365
1,455,131
1,458,693
1,462,172
1,466,604
1,470,862
1,486,853
1,561,096
1,580,891
1,583,653
1,606,142
1,608,749
1,605,898
1,608,730
1,705,607
1,709,144
1,712,558
1,855,659
0
0
001,855,6591,712,5581,709,1441,705,6071,608,7301,605,8981,608,7491,606,1421,583,6531,580,8911,561,0961,486,8531,470,8621,466,6041,462,1721,458,6931,455,1311,451,3651,447,9541,444,9251,441,8901,438,6251,435,5261,433,2631,430,6301,423,9111,411,2221,406,3111,402,1901,399,6651,397,6461,396,2071,394,4211,391,9321,389,9971,181,0151,179,3581,177,4321,175,1081,173,2051,170,9281,168,9611,166,6051,127,8321,090,4851,088,6661,087,033925,230923,797000000000000000000000000000000000000000000000
   Treasury Stock00-2,885-2,885-2,061-2,061-2,061-2,061-7,518-7,518-7,518-7,518-4,843-4,843-4,843-4,740-3,817-3,817-3,817-3,817-2,876-2,876-2,876-2,876-1,904-1,904-1,904-1,904-3,368-3,368-3,368-3,368-2,747-2,747-2,747-2,747-2,390-2,390-2,390-2,390-1,503-1,503-1,503-1,503-630-630-630-630-345-345-345-345-237-237-237-237-88-8800000000000000000000000000000000000000
   Other Stockholders Equity 
68,431
260,105
264,470
268,191
272,065
275,918
314,933
319,142
323,518
329,062
334,072
330,701
330,666
330,767
380,877
380,995
382,189
382,487
382,525
382,666
382,757
383,087
383,193
383,222
385,180
386,995
392,506
437,180
439,589
464,105
663,772
666,702
668,481
670,064
671,484
672,838
674,645
676,001
677,458
809,581
992,283
994,783
918,924
920,087
921,974
923,452
924,885
1,086,688
1,088,036
1,089,855
1,127,202
1,165,975
1,167,458
1,169,425
1,171,702
1,173,605
1,175,042
1,176,968
1,178,625
1,387,607
1,389,185
1,391,674
1,393,460
1,394,899
1,396,297
1,398,822
1,402,943
1,407,854
1,422,007
1,428,726
1,431,359
1,433,622
1,435,749
1,439,014
1,442,049
1,445,078
1,447,548
1,451,314
1,454,876
1,458,355
1,461,864
1,466,019
1,482,010
1,556,253
1,573,373
1,576,135
1,598,624
10
1,603,837
1,606,669
1,703,546
239
-27
-145
-132
1,859,673
1,859,673-132-145-272391,703,5461,606,6691,603,837101,598,6241,576,1351,573,3731,556,2531,482,0101,466,0191,461,8641,458,3551,454,8761,451,3141,447,5481,445,0781,442,0491,439,0141,435,7491,433,6221,431,3591,428,7261,422,0071,407,8541,402,9431,398,8221,396,2971,394,8991,393,4601,391,6741,389,1851,387,6071,178,6251,176,9681,175,0421,173,6051,171,7021,169,4251,167,4581,165,9751,127,2021,089,8551,088,0361,086,688924,885923,452921,974920,087918,924994,783992,283809,581677,458676,001674,645672,838671,484670,064668,481666,702663,772464,105439,589437,180392,506386,995385,180383,222383,193383,087382,757382,666382,525382,487382,189380,995380,877330,767330,666330,701334,072329,062323,518319,142314,933275,918272,065268,191264,470260,10568,431



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,204
Cost of Revenue-639
Gross Profit565565
 
Operating Income (+$)
Gross Profit565
Operating Expense-172,315
Operating Income-171,750-171,750
 
Operating Expense (+$)
Research Development58,333
Selling General Administrative97,704
Selling And Marketing Expenses0
Operating Expense172,315156,037
 
Net Interest Income (+$)
Interest Income6,217
Interest Expense-13,101
Other Finance Cost-4,318
Net Interest Income-2,566
 
Pretax Income (+$)
Operating Income-171,750
Net Interest Income-2,566
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-177,119-166,381
EBIT - interestExpense = -184,851
-177,119
-164,018
Interest Expense13,101
Earnings Before Interest and Taxes (EBIT)-171,750-164,018
Earnings Before Interest and Taxes (EBITDA)-171,196
 
After tax Income (+$)
Income Before Tax-177,119
Tax Provision-0
Net Income From Continuing Ops-157,857-177,119
Net Income-177,119
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses172,954
Total Other Income/Expenses Net-5,3692,566
 

Technical Analysis of Lexicon Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lexicon Pharmaceuticals Inc. The general trend of Lexicon Pharmaceuticals Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lexicon Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lexicon Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.96 < 2.8291 < 3.73.

The bearish price targets are: 1.24 > 1.04 > 0.9596.

Tweet this
Lexicon Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lexicon Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lexicon Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lexicon Pharmaceuticals Inc. The current macd is -0.18388748.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lexicon Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lexicon Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lexicon Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Lexicon Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartLexicon Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lexicon Pharmaceuticals Inc. The current adx is 18.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lexicon Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Lexicon Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lexicon Pharmaceuticals Inc. The current sar is 1.7425201.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lexicon Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lexicon Pharmaceuticals Inc. The current rsi is 33.82. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Lexicon Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartLexicon Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lexicon Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lexicon Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lexicon Pharmaceuticals Inc Daily Stochastic Oscillator ChartLexicon Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lexicon Pharmaceuticals Inc. The current cci is -97.79505798.

Lexicon Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartLexicon Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lexicon Pharmaceuticals Inc. The current cmo is -40.7056372.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lexicon Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartLexicon Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lexicon Pharmaceuticals Inc. The current willr is -90.74359766.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Lexicon Pharmaceuticals Inc Daily Williams %R ChartLexicon Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lexicon Pharmaceuticals Inc. The current atr is 0.15290114.

Lexicon Pharmaceuticals Inc Daily Average True Range (ATR) ChartLexicon Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lexicon Pharmaceuticals Inc. The current obv is 42,471,807.

Lexicon Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartLexicon Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lexicon Pharmaceuticals Inc. The current mfi is 23.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Lexicon Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartLexicon Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lexicon Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lexicon Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lexicon Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.821
Ma 20Greater thanMa 501.867
Ma 50Greater thanMa 1002.229
Ma 100Greater thanMa 2001.929
OpenGreater thanClose1.550
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lexicon Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Lexicon Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lexicon Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lexicon Pharmaceuticals Inc

I send you an email if I find something interesting about Lexicon Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Lexicon Pharmaceuticals Inc.

Receive notifications about Lexicon Pharmaceuticals Inc in your mailbox!